Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteers - Lyden, Patrick; Levy, Howard; Weymer, Sara; Pryor, Kent; Kramer, William; Griffin, John H; Davis, Thomas P; Zlokovic, Berislav (Current pharmaceutical design, 2013)
Keywords: Adult; Anticoagulants - administration & dosage; Anticoagulants - adverse effects; Anticoagulants - pharmacokinetics; Cohort Studies; Healthy Volunteers; Humans; Placebos; Protein C - administration & dosage; Protein C - adverse effects; Protein C - pharmacokinetics; Recombinant Proteins - administration & dosage; Recombinant Proteins - adverse effects; Recombinant Proteins - pharmacokinetics